Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines
Cancers · 30.05.2024 · 16 (11) · 2082
DOI: 10.3390/cancers16112082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.05.2024. Verfasst von Andreas G Tsantes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, G…. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dysregulated hemostasis in cancer patients is associated with various clinical conditions, from thromboembolic complications to disseminated intravascular coagulation. Despite the well-established association between cancer and thromboembolic complications, the mechanisms involved are not completely elucidated. There are several predisposing factors in cancer for increased thrombus generation, such as immobilization and chemotherapy. The term cancer-associated thrombosis (CAT) has been introduced to describe the close bidirectional relationship between cancer and thromboembolic events. Conventional coagulation tests (PT/aPTT) are more accurate in detecting a hypocoagulable rather than a hypercoagulable state; thus, their contribution to CAT management is limited. Traditionally, D-dimer levels have been the most common laboratory study for the evaluation of thrombotic risk. However, D-dimer levels only display a snapshot of the coagulation cascade, and they cannot provide a dynamic evaluation of evolving clot formation. Non-conventional assays, such as viscoelastic methods and microparticle formation are promising tools for the identification of patients at risk for developing CAT. Recent guidelines from the American Society of Clinical Oncology counsel against the estimation of thrombotic risk through a single test and recommend the use of scoring systems that take into account several risk factors. The present review outlines the current insights into the pathophysiological mechanisms of CAT and provides a comprehensive review of the latest advances in the laboratory assessment of CAT and the recent guidelines for the management of patients at risk for developing thromboembolic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Haematology and Blood Bank Unit, "Attiko" Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- Microbiology Department, "Saint Savvas" Oncology Hospital, 11522 Athens, Greece.
- Neonatal Intensive Care Unit, "Agios Panteleimon" General Hospital of Nikea, 18454 Piraeus, Greece.
- 2nd Department of Critical Care, Attikon Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Laboratory of Reliability and Quality Control in Laboratory Hematology (HemQcR), Department of Biomedical Sciences, Section of Medical Laboratories, School of Health & Caring Sciences, University of West Attica (UniWA),…
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.
ORCID-Profile: Andreas G Tsantes, Rozeta Sokou, Frantzeska Frantzeskaki, Daniele Piovani, Georgios K Nikolopoulos, Stefanos Bonovas
Zitieren
APA
Tsantes, A. G., Petrou, E., Tsante, K. A., Sokou, R., Frantzeskaki, F., Domouchtsidou, A., Chaldoupis, A. E., Fortis, S. P., Piovani, D., Nikolopoulos, G. K., Iacovidou, N., Bonovas, S., Samonis, G., & Tsantes, A. E. (2024). Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. Cancers, 16(11), 2082. https://doi.org/10.3390/cancers16112082
Vancouver
Tsantes AG, Petrou E, Tsante KA, Sokou R, Frantzeskaki F, Domouchtsidou A, et al. Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. Cancers. 2024;16(11):2082. doi:10.3390/cancers16112082
BibTeX
@article{Tsantes2024,
author = {Tsantes, Andreas G and Petrou, Eleni and Tsante, Konstantina A and Sokou, Rozeta and Frantzeskaki, Frantzeska and Domouchtsidou, Aglaia and Chaldoupis, Anastasios E and Fortis, Sotirios P and Piovani, Daniele and Nikolopoulos, Georgios K and Iacovidou, Nicoletta and Bonovas, Stefanos and Samonis, George and Tsantes, Argyrios E},
title = {Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines},
journal = {Cancers},
year = {2024},
volume = {16},
number = {11},
pages = {2082},
doi = {10.3390/cancers16112082}
}
EUVIMED